AGEN
Price
$5.16
Change
-$0.47 (-8.35%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
141.47M
RNAZ
Price
$7.25
Change
-$0.14 (-1.89%)
Updated
Jun 5, 04:57 PM (EDT)
Capitalization
6.04M
Interact to see
Advertisement

AGEN vs RNAZ

Header iconAGEN vs RNAZ Comparison
Open Charts AGEN vs RNAZBanner chart's image
Agenus
Price$5.16
Change-$0.47 (-8.35%)
Volume$29.19K
Capitalization141.47M
TransCode Therapeutics
Price$7.25
Change-$0.14 (-1.89%)
Volume$141
Capitalization6.04M
AGEN vs RNAZ Comparison Chart
Loading...
AGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNAZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGEN vs. RNAZ commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGEN is a Buy and RNAZ is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (AGEN: $5.16 vs. RNAZ: $7.25)
Brand notoriety: AGEN and RNAZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGEN: 128% vs. RNAZ: 28%
Market capitalization -- AGEN: $141.47M vs. RNAZ: $6.04M
AGEN [@Biotechnology] is valued at $141.47M. RNAZ’s [@Biotechnology] market capitalization is $6.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGEN’s FA Score shows that 0 FA rating(s) are green whileRNAZ’s FA Score has 1 green FA rating(s).

  • AGEN’s FA Score: 0 green, 5 red.
  • RNAZ’s FA Score: 1 green, 4 red.
According to our system of comparison, both AGEN and RNAZ are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGEN’s TA Score shows that 4 TA indicator(s) are bullish while RNAZ’s TA Score has 4 bullish TA indicator(s).

  • AGEN’s TA Score: 4 bullish, 4 bearish.
  • RNAZ’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, RNAZ is a better buy in the short-term than AGEN.

Price Growth

AGEN (@Biotechnology) experienced а +61.25% price change this week, while RNAZ (@Biotechnology) price change was +5.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.85%. For the same industry, the average monthly price growth was +10.46%, and the average quarterly price growth was -0.86%.

Reported Earning Dates

AGEN is expected to report earnings on Mar 17, 2025.

RNAZ is expected to report earnings on Apr 15, 2025.

Industries' Descriptions

@Biotechnology (+7.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AGEN($141M) has a higher market cap than RNAZ($6.04M). AGEN has higher P/E ratio than RNAZ: AGEN (0.17) vs RNAZ (0.00). AGEN YTD gains are higher at: 88.321 vs. RNAZ (-92.168). RNAZ has higher annual earnings (EBITDA): -16.19M vs. AGEN (-77.64M). AGEN has more cash in the bank: 44.8M vs. RNAZ (5.81M). RNAZ has less debt than AGEN: RNAZ (38.3K) vs AGEN (78.4M). AGEN has higher revenues than RNAZ: AGEN (160M) vs RNAZ (0).
AGENRNAZAGEN / RNAZ
Capitalization141M6.04M2,333%
EBITDA-77.64M-16.19M479%
Gain YTD88.321-92.168-96%
P/E Ratio0.170.0014,558%
Revenue160M0-
Total Cash44.8M5.81M771%
Total Debt78.4M38.3K204,700%
FUNDAMENTALS RATINGS
AGEN: Fundamental Ratings
AGEN
OUTLOOK RATING
1..100
30
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
32

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AGENRNAZ
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 2 days ago
69%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 16 days ago
81%
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 7 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNAZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRSO1.120.16
+16.39%
Peraso
ALDX2.470.12
+5.11%
Aldeyra Therapeutics
AMCR9.07-0.03
-0.33%
Amcor plc
FHB23.59-0.34
-1.42%
First Hawaiian
REPX26.41-1.17
-4.24%
Riley Exploration Permian

RNAZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNAZ has been loosely correlated with NGNE. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RNAZ jumps, then NGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNAZ
1D Price
Change %
RNAZ100%
+5.20%
NGNE - RNAZ
48%
Loosely correlated
+5.40%
ABCZF - RNAZ
37%
Loosely correlated
N/A
BPTSY - RNAZ
33%
Poorly correlated
N/A
AGEN - RNAZ
32%
Poorly correlated
+12.60%
JAGX - RNAZ
31%
Poorly correlated
-4.08%
More